Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket
NCT: NCT05536115 · COMPLETED
Brief Summary
Alveogyl (Septodont, Saint-Maur-des-Fossés - France) is a Medical Device used as dressing in case of dry socket. ALVE study is a clinical investigation measuring Alveogyl performance and safety in patients with post-extraction dry socket. The study takes place in India and in France where Alveogyl is already marketed, since 2010 in France and since 2014 in India .
Frequently Asked Questions
What is Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket?
Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket is a clinical trial registered under NCT05536115. Current status: COMPLETED.
What is the status of NCT05536115?
The current status of NCT05536115 (Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket) is: COMPLETED.
When did Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket start?
Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket started on 2022-12-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.